What does Gwo Xi Stem Cell Applied Technology Co. , Ltd do?

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6704.TWO's market cap?

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) has a market capitalization of approximately $1.84 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6704.TWO pay a dividend?

No — Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6704.TWO profitable?

Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6704.TWO

Gwo Xi Stem Cell Applied Technology Co. , Ltd

TWO·Biotechnology · Healthcare

NT$19.20NT$0.40+2.13%

Market capNT$1.84B·Aug 26 6:50 AM UTC

Price Chart

NT$19.20+NT$0.40 (+2.13%)today

−58.31%CAGR −23.07%

Select date range

FromTo

Apr 26, 2023Apr 26, 2023 → Aug 26, 2026· 3.3 yrsAug 26, 2026

Key Metrics

6704.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 13

Last Report DateAug 12

Reported vs Estimate−NT$0.56

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$157.86M

Net Income−NT$99.04M

Net Margin−62.7%

Operating Cash Flow−NT$42.81M

Capital ExpendituresNT$24.16M

Free Cash Flow−NT$66.98M

Return on Equity−13.3%

Return on Invested Capital−4.6%

Net CashNT$8.55M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6704.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6704.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6704.TWO and 80,000+ other tickers.

About Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for…

CEO: Chuan-Feng Chiu
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 55
Website: www.gwoxi.com

Peers

Steminent Biotherapeutics Inc.

Cap

NT$5.8B

6864.TWO

Anti-Microbial Savior BioteQ Co., Ltd

Cap

NT$1.5B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6704.TWO

What does Gwo Xi Stem Cell Applied Technology Co. , Ltd do?: Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6704.TWO's market cap?: Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) has a market capitalization of approximately $1.84 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6704.TWO pay a dividend?: No — Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6704.TWO profitable?: Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.